We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Vectura Group plc, an inhalation CDMO, and Inspira Pharmaceuticals, a UK-based company focused on developing therapies for respiratory and infectious diseases, entered an agreement to develop an inhaled formulation of Inspira’s lead drug candidate ...